ID30481A - Formulasi yang terdiri dari testosteron undekanoat dan minyak kastor - Google Patents

Formulasi yang terdiri dari testosteron undekanoat dan minyak kastor

Info

Publication number
ID30481A
ID30481A IDW00200102082A ID20012082A ID30481A ID 30481 A ID30481 A ID 30481A ID W00200102082 A IDW00200102082 A ID W00200102082A ID 20012082 A ID20012082 A ID 20012082A ID 30481 A ID30481 A ID 30481A
Authority
ID
Indonesia
Prior art keywords
testosterone
solution
liquid carrier
castor oils
undecanoate
Prior art date
Application number
IDW00200102082A
Other languages
English (en)
Indonesian (id)
Inventor
Nijs De Henrik
Chandler Susan
Perry Elizabeth Anne
Ferdinando Josephine Christine
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of ID30481A publication Critical patent/ID30481A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Fats And Perfumes (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Steroid Compounds (AREA)
IDW00200102082A 1999-04-01 2000-03-27 Formulasi yang terdiri dari testosteron undekanoat dan minyak kastor ID30481A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP99302581 1999-04-01

Publications (1)

Publication Number Publication Date
ID30481A true ID30481A (id) 2001-12-13

Family

ID=8241306

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW00200102082A ID30481A (id) 1999-04-01 2000-03-27 Formulasi yang terdiri dari testosteron undekanoat dan minyak kastor

Country Status (27)

Country Link
EP (1) EP1189620B1 (xx)
JP (1) JP2002541111A (xx)
KR (1) KR100666016B1 (xx)
CN (1) CN1155385C (xx)
AT (1) ATE269708T1 (xx)
AU (1) AU768537B2 (xx)
BR (1) BR0009465A (xx)
CA (1) CA2366856C (xx)
CZ (1) CZ298573B6 (xx)
DE (1) DE60011771T2 (xx)
DK (1) DK1189620T3 (xx)
ES (1) ES2222199T3 (xx)
HK (1) HK1043544A1 (xx)
HU (1) HU229455B1 (xx)
ID (1) ID30481A (xx)
IL (2) IL145524A0 (xx)
MX (1) MXPA01009919A (xx)
NO (1) NO329420B1 (xx)
NZ (1) NZ514290A (xx)
PL (1) PL195163B1 (xx)
PT (1) PT1189620E (xx)
RU (1) RU2246296C2 (xx)
SK (1) SK286071B6 (xx)
TR (1) TR200102769T2 (xx)
TW (1) TWI280124B (xx)
WO (1) WO2000059512A1 (xx)
ZA (1) ZA200107781B (xx)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6652880B1 (en) 1999-04-01 2003-11-25 R.P. Scherer Technologies, Inc. Oral pharmaceutical compositions containing long-chain triglycerides and liphophilic surfactants
GB9907715D0 (en) * 1999-04-01 1999-05-26 Scherer Corp R P Pharmaceutical compositions
JO2505B1 (en) * 2003-03-14 2009-10-05 باير شيرنغ فارما اكتنجيسيلشافت Pharmacy methods and formulations for obtaining acceptable serum testosterone levels
US8784869B2 (en) 2003-11-11 2014-07-22 Mattern Pharma Ag Controlled release delivery system for nasal applications and methods of treatment
DE60303854T2 (de) * 2003-11-11 2006-08-10 Mattern, Udo Nasenformulierung mit kontrollierter Freisetzung von Sexualhormonen
US20060140820A1 (en) 2004-12-28 2006-06-29 Udo Mattern Use of a container of an inorganic additive containing plastic material
US8492369B2 (en) 2010-04-12 2013-07-23 Clarus Therapeutics Inc Oral testosterone ester formulations and methods of treating testosterone deficiency comprising same
EP2979699A1 (en) 2005-04-15 2016-02-03 Clarus Therapeutics, Inc. Pharmaceutical delivery systems for hydrophobic drugs and compositions comprising same
CN101600417B (zh) 2006-10-04 2012-05-30 M&P专利股份公司 用于神经递质的经鼻施用的控制释放递送系统
GB0818473D0 (en) 2008-10-08 2008-11-12 Probio Nutraceuticals As Composition
US11304960B2 (en) 2009-01-08 2022-04-19 Chandrashekar Giliyar Steroidal compositions
BR112012025961B1 (pt) * 2010-04-12 2021-06-15 Clarus Therapeutics, Inc Composição farmacêutica oral
GB201006200D0 (en) * 2010-04-14 2010-06-02 Ayanda As Composition
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US9358241B2 (en) 2010-11-30 2016-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
SG192114A1 (en) * 2011-01-26 2013-08-30 Allergan Inc Androgen composition for treating an opthalmic condition
US9757388B2 (en) 2011-05-13 2017-09-12 Acerus Pharmaceuticals Srl Intranasal methods of treating women for anorgasmia with 0.6% and 0.72% testosterone gels
US20130045958A1 (en) 2011-05-13 2013-02-21 Trimel Pharmaceuticals Corporation Intranasal 0.15% and 0.24% testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorder
US20130040923A1 (en) 2011-05-13 2013-02-14 Trimel Pharmaceuticals Corporation Intranasal lower dosage strength testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorder
US11744838B2 (en) 2013-03-15 2023-09-05 Acerus Biopharma Inc. Methods of treating hypogonadism with transnasal testosterone bio-adhesive gel formulations in male with allergic rhinitis, and methods for preventing an allergic rhinitis event
MX2016016612A (es) 2014-06-17 2017-03-20 Merck Sharp & Dohme Formulaciones estables de undecanoato de testosterona.
CN107073127A (zh) * 2014-06-19 2017-08-18 索露奥公司 亲脂性化合物的固体口服剂型
US9498485B2 (en) 2014-08-28 2016-11-22 Lipocine Inc. Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters
WO2016033549A2 (en) 2014-08-28 2016-03-03 Lipocine Inc. (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
RU2017111503A (ru) * 2014-08-29 2018-10-05 Липосин Инк. КОМПОЗИЦИИ(17-β)-3-ОКСОАНДРОСТ-4-ЕН-17-ИЛ УНДЕКАНОАТА И СПОСОБЫ ИХ ПОЛУЧЕНИЯ И ПРИМЕНЕНИЯ
EP3544614A4 (en) 2016-11-28 2020-08-05 Lipocine Inc. ORAL TESTOSTERONE UNDECANOATE THERAPY

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1102095A (zh) * 1993-10-30 1995-05-03 浙江医科大学 长效雄激素类制剂——十一酸睾丸注射液
GB9608719D0 (en) * 1996-04-26 1996-07-03 Scherer Ltd R P Pharmaceutical compositions
SE9700642D0 (sv) * 1997-02-24 1997-02-24 Kronvall Stefan Med Ab Medel och sätt för förebyggande och behandling av det metabola syndromet

Also Published As

Publication number Publication date
PL195163B1 (pl) 2007-08-31
RU2246296C2 (ru) 2005-02-20
DE60011771T2 (de) 2004-11-04
HK1043544A1 (en) 2002-09-20
AU4111100A (en) 2000-10-23
NO20014718L (no) 2001-09-28
IL145524A (en) 2006-12-31
DK1189620T3 (da) 2004-08-16
KR20010108435A (ko) 2001-12-07
SK13722001A3 (sk) 2002-02-05
CN1155385C (zh) 2004-06-30
CN1346274A (zh) 2002-04-24
HUP0200453A2 (hu) 2002-07-29
MXPA01009919A (es) 2002-04-24
KR100666016B1 (ko) 2007-01-10
CZ298573B6 (cs) 2007-11-14
ES2222199T3 (es) 2005-02-01
ATE269708T1 (de) 2004-07-15
TR200102769T2 (tr) 2002-05-21
SK286071B6 (sk) 2008-02-05
CA2366856C (en) 2006-05-16
ZA200107781B (en) 2002-12-20
IL145524A0 (en) 2002-06-30
NZ514290A (en) 2003-08-29
BR0009465A (pt) 2002-01-08
AU768537B2 (en) 2003-12-18
TWI280124B (en) 2007-05-01
EP1189620A1 (en) 2002-03-27
JP2002541111A (ja) 2002-12-03
WO2000059512A1 (en) 2000-10-12
HU229455B1 (en) 2013-12-30
HUP0200453A3 (en) 2003-06-30
EP1189620B1 (en) 2004-06-23
CA2366856A1 (en) 2000-10-12
PT1189620E (pt) 2004-10-29
NO20014718D0 (no) 2001-09-28
DE60011771D1 (de) 2004-07-29
PL351259A1 (en) 2003-04-07
CZ20013507A3 (cs) 2002-03-13
NO329420B1 (no) 2010-10-18

Similar Documents

Publication Publication Date Title
ID30481A (id) Formulasi yang terdiri dari testosteron undekanoat dan minyak kastor
RU2001129362A (ru) Композиция, включающая ундеканоат тестостерона и касторовое масло
DK1173153T3 (da) Orale farmaceutiske præparater, som indeholder langkædede triglycerider og lipofile overfladeaktive midler
US10463614B2 (en) Butylphthalide intravenous emulsion and application thereof
KR950031069A (ko) 골손실의 억제 및 혈청 콜레스테롤의 강하 방법
EP0904064A1 (en) Oral pharmaceutical compositions containing sex hormones
PL318560A1 (en) Novel orally administered preparations containing cyclosporin of simple composition and high bioavailability
BRPI0008228B1 (pt) composição farmacêutica contendo n-benzoil estaurosporina e agentes solubilizantes
WO2000057918A2 (en) Novel formulations comprising lipid-regulating agents
NO950134L (no) Formuleringer for oralt administrerte farmasöytiske midler
KR19980071702A (ko) 유제용 보존제 및 이를 함유한 유제
JP2010529175A (ja) マラセチア属酵母に対して抗真菌活性を有するテルペン
KR100570450B1 (ko) 가용성 로바스타틴의 연질캡슐제 조성물 및 그의 제조방법
AR023235A1 (es) Formulaciones de androgenos
MXPA05008921A (es) Formulaciones orales semisolidas para liberacion inmediata que comprenden un agente hidrofobo anticancer, un glicerido poliglicolisado y un vehiculo hidrofilo.
AU3043400A (en) Cyclosporin solution
US20060024341A1 (en) Microemulsion composition and related method
TH33003B (th) สูตรตำรับแอนโดรเจน
TH60756A (th) สูตรตำรับแอนโดรเจน
MY130474A (en) Oral pharmaceutical compositions containing long-chain triglycerides and lipophilic surfactants
KR20010011249A (ko) 페노피브레이트를 함유하는 경구용 마이크로에멀젼 조성물
TH34374B (th) องค์ประกอบเชิงเภสัชกรรมชนิดที่เป็นของแข็งซึ่งประกอบด้วยอนุพันธ์เบนโซฟูแรน
TH40043A (th) องค์ประกอบเชิงเภสัชกรรมชนิดที่เป็นของแข็งซึ่งประกอบด้วยอนุพันธ์เบนโซฟูแรน
TH18778A (th) สูตรผสมสำหรับสารทางเคมีเภสัชศาสตร์ที่ให้ทางปาก
MXPA99006916A (en) Oil-free pharmaceutical compositions containing cyclosporin a